1. Home
  2. COEP vs SCWO Comparison

COEP vs SCWO Comparison

Compare COEP & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • SCWO
  • Stock Information
  • Founded
  • COEP 2017
  • SCWO 2021
  • Country
  • COEP United States
  • SCWO United States
  • Employees
  • COEP N/A
  • SCWO N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • SCWO Environmental Services
  • Sector
  • COEP Health Care
  • SCWO Utilities
  • Exchange
  • COEP Nasdaq
  • SCWO Nasdaq
  • Market Cap
  • COEP 62.4M
  • SCWO 58.8M
  • IPO Year
  • COEP N/A
  • SCWO N/A
  • Fundamental
  • Price
  • COEP $12.96
  • SCWO $0.37
  • Analyst Decision
  • COEP
  • SCWO
  • Analyst Count
  • COEP 0
  • SCWO 0
  • Target Price
  • COEP N/A
  • SCWO N/A
  • AVG Volume (30 Days)
  • COEP 45.5K
  • SCWO 1.1M
  • Earning Date
  • COEP 11-12-2025
  • SCWO 11-12-2025
  • Dividend Yield
  • COEP N/A
  • SCWO N/A
  • EPS Growth
  • COEP N/A
  • SCWO N/A
  • EPS
  • COEP N/A
  • SCWO N/A
  • Revenue
  • COEP $263,555.00
  • SCWO $1,231,413.00
  • Revenue This Year
  • COEP N/A
  • SCWO $5,945.19
  • Revenue Next Year
  • COEP N/A
  • SCWO $106.82
  • P/E Ratio
  • COEP N/A
  • SCWO N/A
  • Revenue Growth
  • COEP N/A
  • SCWO 403.17
  • 52 Week Low
  • COEP $2.31
  • SCWO $0.16
  • 52 Week High
  • COEP $14.70
  • SCWO $1.99
  • Technical
  • Relative Strength Index (RSI)
  • COEP 54.10
  • SCWO 59.66
  • Support Level
  • COEP $12.09
  • SCWO $0.37
  • Resistance Level
  • COEP $13.53
  • SCWO $0.41
  • Average True Range (ATR)
  • COEP 0.74
  • SCWO 0.05
  • MACD
  • COEP -0.12
  • SCWO 0.00
  • Stochastic Oscillator
  • COEP 56.55
  • SCWO 64.12

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About SCWO 374Water Inc.

374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.

Share on Social Networks: